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In isolated hepatocytes the entry into urea of metabolic 14C0, derived from [‘“cl formate is modified by 
the addition of dichloroacetate and hydroxypyruvate. An explanation is that this results from changes in 
the cytoplasmic/mitochondrial pH gradient. ‘TO, derived from [I-‘Tlalanine enters into urea more readily 
than “‘CO, arising from [ 1-W]glutamate. It is proposed that the difference, which is more than 4-fold, is 
indicative of a preferred pathway for metabolic CO, in liver mitochondria from pyruvate dehydrogenase 
to carbamoylphosphate synthetase than form oxoglutarate dehydrogenase. Acetazolamide inhibition of car- 
bonic anhydrase is without effect on this observed incorporation into urea. 
Hepatocyte Mitochondria Urea synthesis Enzyme location CO, compartmentation 
CytosoliclmitochondrialpH gradient 
1. INTRODUCTION 
In isolated hepatocytes, metabolic CO2 has been 
shown to enter into urea more readily than the ex- 
ogeneous bicarbonate plus CO2 from the suspen- 
ding medium [l]. Substrates which, when 
metabolised, affect the pH of the cell (dichloro- 
acetate and hydroxypyruvate) have been shown to 
modify the fixation of i4C02 into urea [2]. The 
direction of the change in specific activity of urea, 
positive or negative, depends on two factors. First, 
the direction of the shift in intracellular pH which 
the modifiers cause, and second, the site of origin 
(extracellular or intracellular) of the H14C03 fixed 
into carbamoylphosphate. Formate is metabolised 
in isolated hepatocytes by the formation of the 
tetrahydrofolate compound and through the 
NADP-linked formyltetrahydrofolate, dehydro- 
genase CO2 is formed in the cytosol [3,4]. The ef- 
fect of dichloroacetate and hydroxypyruvate on 
the incorporation into urea of cytosolic 14C02 
from 14C formate has been examined. 
When [l-14C]alanine is oxidized in isolated 
hepatocytes, a principle site of 14C02 production is 
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pyruvate dehydrogenase (PDH). This is indicated 
by the increase of more than 100% in the forma- 
tion of i4C02 from [l-14C]alanine on addition of 
dichloroacetate. When [l-14C]glutamate is the sub- 
strate, the site of formation of i4C02 is oxo- 
glutarate dehydrogenase. These enzymes are 
located in the mitochondrial matrix. A study in 
hepatocytes from 48-h starved rats of the relative 
rates of incorporation of 14C02 derived from these 
two substrates reveals that CO2 from alanine enters 
into urea with greater facility than CO2 derived 
from glutamate. 
2. MATERIALS AND METHODS 
Isolated hepatocytes were prepared from 48-h 
starved rats of the Wistar strain as in [5] with the 
modifications described in [6]. The method of in- 
cubation, collection of 14C02, and measurement of 
the specific activity of urea was as in [1,2]. 
Radioactive substrates were obtained from Amer- 
sham International (Amersham, Bucks). The 
ethanol which they contained was removed by 
rotary evaporation to dryness and the residue was 
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redissolved in water. Dichloroacetic acid (DCA), 
hydroxypyruvate and urease grade V were supplied 
by Sigma (Poole, Dorset). Enzymes and coen- 
zymes were obtained from Boehringer (Lewes, 
East Sussex). 
3. RESULTS 
3.1. Effect of dichloroacetate and hydroxy- 
pyruvate on the incorporation of cytoplasmic 
CO2 into urea 
The results in table 1, experiment 1, show that 
dichloroacetate markedly changes the specific ac- 
tivity of urea and that the magnitude of the change 
depends on the site of origin of the H14C07 used 
in the carbamoylphosphate synthetase reaction. 
When the site of formation was mitochondrial 
(flasks 1 and 2 contained [l-14C]alanine), the effect 
of dichloroacetate was to lower the specific activity 
of urea by more than 40%. Because dichloro- 
acetate stimulated the production of labelled COZ 
by over loo%, the overall effect of DCA on the en- 
try of mitochondrial metabolic CO2 into urea (cor- 
rected for a zero change in labelled CO2 produc- 
tion) may be as great as - 150%. An explanation 
of this result is that DCA causes a rapid efflux of 
metabolic CO2 from mitochondria. In contrast, 
the effect of DCA on the incorporation into urea 
of CO2 formed in the cytosol from formate was 
much smaller. However, cytosolic CO2 must enter 
the mitochondria in order to be incorporated into 
urea, and in the face of an increase in the efflux of 
CO2 from mitochondria a decrease in the incor- 
poration of cytosolic CO2 is to be expected. 
Table 1 
Effect of dichloroacetate and hydroxypyruvate on the entry of 14C into urea from [l-‘4C]alanine and [r4C]formate in 
isolated hepatocytes from 48-h starved rats 
Radioac- Percent change in Radioac- Urea Specific Percent change in Percent change in 
tivity in dpm in CO2 tivity in formed activity in specific activity of specific activity of 
co2 urea &mol/ urea (dpm urea urea corrected for 
(dpm/flask (dpm/flask flask) x 10-3/ zero change in 
x10-q x 10-3) Icmol) co2 
Exp. 1 plus 
dichloro- 
acetate 
91.7 6.5 1.27 5.1 
186.6 + 103.5 f 16.7 (3) 4.1 1.44 28.5 -44.3+ 7.6 (3) - 147.8k24.1 (3) 
1161.5 19.7 1.35 14.6 
1119.9 3.6* 5.6 (3) 19.7 1.46 13.5 - 6.8+ 4.8 (3) - - 3.2+ 9.2 (3)” 
Exp. 2 plus 
hyroxy- 
pyruvate 
1 84.4 10.1 2.33 4.33 
2 54.3 - 35.7* 3.3 (3) 18.7 1.84 10.16 + 134.7k51.9 (3) + 170.4254.6 (3) 
3 458.8 13.2 2.41 5.46 
4 560.7 + 22.2* 14.6 (3) 15.1 1.96 7.69 +40.7+27.9 (3) + 18.5 f 14.0 (3)b 
Flasks 1 and 2 contained 5 mM [l-‘4C]alanine, 2 mM formate, 0.5 mM methionine. Flasks 3 and 4 contained 5 mM 
alanine, 2 mM [‘4C]formate and 0.5 mM methionine. Dichloroacetate (2 mM) or hydroxypyruvate (2 mM) was added 
to flasks 2 and 4 as shown. Each flask contained a 4-ml suspension of hepatocytes in Krebs-Henseleit saline [lo]. The 
mean wet weight of cells was 88.2 f 16.2 mg SD (6). Flasks were incubated in duplicate for 30 min at 38°C. The values 
for radioactivity and urea are means of 3 experiments. Because of variation in cell content of individual experiments, 
statistics are presented only on the percentage changes. P values (a<0.0006; b<0.009) are calculated for the effects of 
origin of the metabolic CO2 
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In experiment 2, table 1, the addition of 
hydroxypyruvate had the opposite effect to di- 
chloroacetate. The efflux of CO2 from mito- 
chondria was decreased, thereby preserving CO2 
for fixation into urea. The increase in specific ac- 
tivity of urea which resulted from mitochondrial 
14C02 (corrected for zero change in COz) was 
about 170%. In the case of cytoplasmic CO2 the in- 
crease was much smaller (18.5% corrected value). 
Our previous proposal was that dichloroacetate 
and hydroxypyruvate, when metabolised, resulted 
in an increase or decrease in the cytoplasmic/mito- 
chondrial pH gradient and that this affects the in- 
corporation of both intracellular and extracellular 
bicarbonate plus CO2 into urea in opposite direc- 
tions. The results obtained with [14C]formate in- 
dicate more specifically that this applies to cyto- 
solic, rather than extracellular COz. 
3.2. Dependence on the site of origin of mito- 
chondrial metabolic CO2 on its incorporation 
into urea 
Table 2 presents results which show that the pro- 
portion of metabolic 14C02 resulting from the ox- 
idation of [l-14C]alanine or [l-14]glutamate nter- 
ing into urea may differ by a factor of more than 
four. 
In flasks l-4 the main source of both urea car- 
bon and urea nitrogen is alanine, only the source 
of metabolic 14C02 varies. In flasks 5 and 6 the 
main supply of nitrogen is NH&I while the carbon 
for urea is derived mainly from asparagine. The 
14C02 which is incorporated into urea is derived 
either from ‘carrier free’ [l-‘4C]alanine or [1-14C]- 
glutamate. In both cases the concentration of the 
labelled substrate wa 0.01 mM. A comparison of 
the proportion of 14C02 entering urea to the total 
metabolic 14C02 formed shows that CO2 derived 
Table 2 
Effect of acetazolamide and substrate concentration on the incorporation of 14C into urea from [l-‘4C]glutamate 
Flask no. 1 2 3 4 5 6 
Total radioactivity in 
flask (dpm x 10m4) 
Radioactivity in COZ + HCOS 
(dpm x 10-4/flask) 
Specific activity of CO2 + 
HCOT (dpm x lo-’ pmol) 
Urea found @mol/flask) 
Radioactivity in urea 
(dpm x IO-‘/flask 
Specific activity of urea 
dpm x lo-‘/pmol) 
Ratio 
specific activity urea 
specific activity COz + HCO? 
Each flask contained a 4-ml suspension of isolated hepatocytes from 48-h starved rats. The mean weight of cells was 85.06+9.0 SD 
per flask. Flasks 1 and 2 contained 5 mM [l-‘4C]alanine; flasks 3 and 4 contained 5 mM alanine and 0.2,&i [l-‘4C]glutamate ‘carrier- 
free’. Acetazolamide (0.5 mM) was added to flasks 2 and 4. Flasks 5 and 6 contained 1 mM asparagine, 2 mM NH4Cl and 0.5 mM 
ornithine. In addition, flask 5 contained 0.1 &i [l-r4C]alanine and flask 6, 0.2 &i [1-r4C]glutamate, both ‘carrier-free’. Flasks were 
incubated for 30 min at 38°C in duplicate. Values are means + SD for 3 experiments. P values are calculated for the differences in 
ratios between [1-r4C]alanine and [l-r4C]glutamate-derived urea: a<0.002; b<0.006. The specific activity of COz + HCOS is based 
on the acid volatile COZ found of 144.6 pmol + 7.9 SD (42) per flask. When carrier-free substrates were used, without additional 
substrate, the final concentration was 0.01 mM. Ethanol added as a preservative to radiochemicals was removed by rotary evaporation 
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49.2 f 0.59 49.6 + 0.48 49.9 to.19 51.1 +2.0 23.7 * 0.65 49.9 * 0.54 
3.7 * 0.79 3.5 f 0.44 12.2 + 1.8 11.7 +2.6 5.8 + 1.5 13.0 + 1.1 
2.44* 0.38 2.31 t 0.22 8.08+0.11 7.82kO.16 3.82+ 0.74 8.65+ 0.74 
1.58* 0.41 1.25+ 0.34 1.54 + 0.46 1.21 kO.33 1.58+ 0.51 1.55+ 0.61 
25.4 k12.9 21.2 +11.1 21.0 f7.4 20.1 k9.0 48.9 +28.5 52.4 +21.0 
15.091~0.36 16.03 + 0.44 13.99kO.47 16.05 + 0.59 29.77 + 0.98 38.47* 2.0 
6.11+ 0.50 6.86& 1.3 1.32+0.14a 1.47 + 0.26” 8.47+ 3.6 3.14+ 0.62b 
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from [l-‘4C]alanine enters into urea with greater 
facility than CO2 derived from [ 1-i4C]glutamate. 
The differences are up to 4.5fold in favour of 
alanine, and are independent of the origin of the 
urea nitrogen. 
Acetazolamide is without effect on the incor- 
poration of radioactivity into urea. There is some 
indication of a decrease in the synthesis of urea 
from alanine (1.56 PM/flask to 1.23 FM) in the 
presence of acetazolamide (means of 6 values) but 
this is not statistically significant. The results show 
that, independent of the origin of the nitrogen of 
urea, metabolic mitochondrial CO2 does not enter 
into carbamoylphosphate synthesis equally from 
all the sites of formation. 
4. DISCUSSION 
The work in [7] has drawn attention to the extent 
to which metabolic CO2 may undergo fixation into 
intermediate products without equilibration with 
the general pool of bicarbonate plus COz. Further 
work [l] confirmed this by showing that metabolic 
CO2 enters into urea synthesis more readily than it 
exchanges with the medium bicarbonate plus COz, 
and the CO2 of the gas phase. Later experiments 
[2] showed that dichloroacetate and hydroxy- 
pyruvate alter the relative incorporation into urea 
of 14C02, generated in the mitochondria from 
[l-14C]alanine or from H14COY added to the 
medium. The direction in which these changes oc- 
cur depends on the site of origin of the incor- 
porated label. It was concluded that the effects 
resulted from opposing shifts in the pH of the ex- 
tracellular or mitochondrial compartments. 
Here, 14COz generated in the cytosolic compart- 
ment from [14C]formate behaved in a similar man- 
ner to the H14COS added to the medium. It is con- 
cluded that a more precise statement of the effect 
is that dichloroacetate and hydroxypyruvate alter 
the mitochondrial/cytosolic pH gradient in op- 
posite directions resulting in the loss or retention 
of labelled CO2 at the site of fixation, as HCOj_, 
into carbamoylphosphate. Furthermore, the dif- 
ference in the observed ratios of specific activity of 
urea to specific activity of total bicarbonate, which 
results from mitochondrial or cytosolic metabolic 
CO2 (9.54 and 18.5, respectively) is indicative of 
mitochondrial/cytosolic compartmentation of 
COz. This is contrary to the statement in [8]. 
However, in that work the period of incubation 
was 1 h. In earlier work from this laboratory we 
noted that the effect was greater in the early part 
of the time course, and as expected the obervable 
effects declined as the label became distributed 
throughout the total bicarbonate pool. 
Acetazolamide, a specific inhibitor of carbonic 
anhydrase, has been shown to inhibit citrulline 
synthesis in isolated mitochondria from guinea pig 
liver at concentrations of about 50 PM [8]. In the 
present experiments, using isolated rat hepato- 
cytes, acetazolamide at a concentration of 5OOpM, 
depressed urea synthesis from alanine by only 20% 
and this value was not statistically significant. 
Similarly, the entry into urea of metabolic 14C02 
was not significantly affected. In [9] it was shown 
that 50 PM acetazolamide inhibits gluconeogenesis 
and ureogenesis in isolated hepatocytes only in a 
medium low in bicarbonate. In Krebs-Henseleit bi- 
carbonate saline [lo] the effect of acetazolamide 
was marginal. 
Evidence of microcompartmentation or sub- 
strate channelling in mitochondria has been 
reported in [ 1 l] and [ 121. The latter defined micro- 
compartmentation as a situation in which a 
metabolite appears to move from an enzyme by 
which it is synthesized to a second enzyme for 
which it is a substrate without first mixing with the 
total metabolite pool in the same compartment. 
This definition may be extended to include a situa- 
tion where a metabolite which is the product of 
more than one enzyme in the same compartment is 
used by another enzyme more readily from one 
source than from the other. 
Authors in [l l] considered the several 
possibilities which may account for apparent com- 
partmentation including the existence of separate 
metabolite pools, heterogeneity of isolated liver 
cells with differing metabolic roles or the possibili- 
ty of different mitochondrial types. 
The author in [ 131 has discussed at length the 
evidence for a spatial arrangement of enzymes into 
microenvironments in which, because of the prox- 
imity of enzymes of production and utilisation, 
channelling of a metabolite may occur. 
From these present findings one may conclude 
that, assuming that the Krebs cycle enzymes are 
organized in a multi-enzyme complex, oxo- 
glutarate dehydrogenase is placed in a less advan- 
tageous position as a supplier of CO2 to car- 
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bamoylphosphate synthetase, than pyruvate de- 
hydrogenase. The multiple role which pyruvate de- 
hydrogenase plays might be expected to place it 
outside of a Krebs cycle enzyme microenviron- 
ment, as proposed in [13]. 
The ready accessibility of CO2 from pyruvate 
dehydrogenase to carbamoylphosphate synthetase 
and the comparative inaccessibility of COz from 
oxoglutarate dehydrogenase is indicative of some 
form of compartmentation of COz within the liver 
mitochondria, in spite of the free diffusion of CO2 
[ 141. It is possible that the hydration of CO2 occurs 
so close to the site of formation that the dif- 
ferences which are reported must be considered in 
terms of the less diffusible bicarbonate ion [14]. 
Heterogeneous distribution of glutamine syn- 
thetase in rat liver parenchymal cells has been 
reported in [15] where it was shown that this en- 
zyme is found in only 7-8070 of the cell population. 
In [16] it was found that carbamoylphosphate syn- 
thetase has a distribution complementary to that of 
glutamine synthetase which places it in the majori- 
ty of the parenchymal cells. 
Authors in [17] have calculated that carbamoyl- 
phosphate synthetase (ammonia) may constitute 
between 22-26% of the matrix protein and that, 
based on the daily urea output of the adult rat, on 
average only about 8% of the capacity of this en- 
zyme is used. In the experiments reported here the 
rates of urea synthesis are sufficiently low as to 
leave considerable spare capacity. In view of this, 
it is perhaps surprising that there are such marked 
differences in the utilization of metabolic COZ, and 
it serves to strengthen the conclusion that the oxo- 
glutarate dehydrogenase is isolated in a micro- 
environment. 
For cell heterogeneity to play a role in the pre- 
sent findings, some form of separation of the car- 
bamoylphosphate synthetase containing cells on 
the basis of oxoglutarate or alanine oxidation 
would be necessary and this seems very unlikely. 
Similar conditions would apply in the considera- 
tion of mitochondrial heterogeneity. However, if 
mitochondrial carbonic anhydrase is implicated in 
carbamoylphosphate synthesis as proposed in [8], 
its location adjacent to pyruvate dehydrogenase, 
and distant from oxoglutarate dehydrogenase, 
could account for the present observation. Failure 
to find an effect of acetazolamide does not support 
this proposition. 
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